Cargando…

The treatment of Graves' disease in children and adolescents

Graves' disease (GD) accounts for 10%-15% of thyroid disorders in children and adolescents. The use of antithyroid drugs as the initial treatment option in GD is well accepted. An average two years remission is achieved in about 30% of children treated with antithyroid drugs. However, the optim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hae Sang, Hwang, Jin Soon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pediatric Endocrinology 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208256/ https://www.ncbi.nlm.nih.gov/pubmed/25346915 http://dx.doi.org/10.6065/apem.2014.19.3.122

Ejemplares similares

Effects of short-term potassium iodide treatment for thyrotoxicosis due to Graves disease in children and adolescents
por: Jeong, Kyung Uk, et al.
Publicado: (2014)

Long-term outcomes of Graves’ disease in children and adolescents receiving antithyroid drugs
por: Rho, Jung Gi, et al.
Publicado: (2021)

Thyrotoxic hypokalemic periodic paralysis due to Graves’ disease in 2 adolescents
por: Roh, Jung Gi, et al.
Publicado: (2019)

Graves’ Disease in Children: An Update
por: Metwalley, Kotb Abbass, et al.
Publicado: (2023)

Hashimoto’s Thyroiditis in children and adolescents: at presentation and during long-term follow up
por: Kim, You Jin, et al.
Publicado: (2013)

Clinical characteristics and laboratory findings of children and adolescents who were newly diagnosed with diabetes mellitus
por: Kim, You Jin, et al.
Publicado: (2013)

Metabolic risk assessment in children and adolescents using the tri-ponderal mass index
por: Seo, Young-Jun, et al.
Publicado: (2022)

Hemoglobin and hematocrit levels are positively associated with blood pressure in children and adolescents 10 to 18 years old
por: Jeong, Hwal Rim, et al.
Publicado: (2021)

Behavioral assessment of children and adolescents with Graves’ disease: A prospective study
por: Hamed, Sherifa Ahmed, et al.
Publicado: (2021)

Considerations for Thyroidectomy as Treatment for Graves Disease
por: Smithson, Mary, et al.
Publicado: (2019)

Antithyroid Drug Treatment in Graves’ Disease
por: Chung, Jae Hoon
Publicado: (2021)

Updated reference ranges for aminotransferase levels of Korean children and young adolescents based on the risk factors for metabolic syndrome
por: Seo, Young-Jun, et al.
Publicado: (2022)

ODP574 Characteristics of Grave's Disease Among Children and Adolescents in KSA
por: Alradadi, Rasha, et al.
Publicado: (2022)

Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
por: Lee, Hyun Gyung, et al.
Publicado: (2021)

Serum Lipid Concentrations, Prevalence of Dyslipidemia, and Percentage Eligible for Pharmacological Treatment of Korean Children and Adolescents; Data from the Korea National Health and Nutrition Examination Survey IV (2007–2009)
por: Yang, Seung, et al.
Publicado: (2012)

Treatment of congenital hypogonadotropic hypogonadism in male patients
por: Lee, Hae Sang, et al.
Publicado: (2022)

Predictive factors for early response to methimazole in children and adolescents with Graves disease: a single-institute study between 1993 and 2013
por: Hwang, Sun Mi, et al.
Publicado: (2016)

The Treatment of Graves' Disease
por: Herapath, C. E. K.
Publicado: (1930)

A population-based study of TyG index distribution and its relationship to cardiometabolic risk factors in children and adolescents
por: Yoon, Jong Seo, et al.
Publicado: (2021)

Positive Associations between Body Mass Index and Hematological Parameters, Including RBCs, WBCs, and Platelet Counts, in Korean Children and Adolescents
por: Jeong, Hwal Rim, et al.
Publicado: (2022)

Graves’ Disease in Albanian Children
por: GJIKOPULLI, A., et al.
Publicado: (2014)

Graves disease is more prevalent than Hashimoto disease in children and adolescents with type 1 diabetes
por: Wang, Lu-Ting, et al.
Publicado: (2023)

The Treatment of Graves's Disease
Publicado: (1906)

Long-Term Antithyroid Drug Treatment of Graves’ Disease in Children and Adolescents: A 20-Year Single-Center Experience
por: Song, Ari, et al.
Publicado: (2021)

Characteristics of Graves' disease in children and adolescents in Nanjing: A retrospective investigation study
por: Xie, Hang, et al.
Publicado: (2022)

Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves' disease
por: Cury, Adriano N, et al.
Publicado: (2012)

Long-term monitoring of Graves’ disease in children and adolescents: a single-center experience
por: TUNÇ, Selma, et al.
Publicado: (2019)

Microchimerism in Graves' Disease
por: Galofré, Juan C.
Publicado: (2012)

Multiple Fractures in Patient with Graves' Disease Accompanied by Isolated Hypogonadotropic Hypogonadism
por: Yi, Hyon-Seung, et al.
Publicado: (2016)

Impact of Methimazole Treatment on Magnesium Concentration and Lymphocytes Activation in Adolescents with Graves’ Disease
por: Klatka, Maria, et al.
Publicado: (2013)

Hyperosmolar hyperglycemic state as the first manifestation of type 1 diabetes mellitus in an adolescent male: a case report
por: Chun, Sang Hoon, et al.
Publicado: (2022)

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy
por: Duntas, Leonidas H.
Publicado: (2012)

Genetic aspects of type 1 diabetes
por: Lee, Hae Sang, et al.
Publicado: (2019)

Commentary on "Long-term outcomes of Graves’ disease in children and adolescents receiving antithyroid drugs"
por: Kim, Minsun
Publicado: (2021)

Graves of Graves' Disease, 1796—1853
por: Taylor, Selwyn
Publicado: (1986)

Graves’ disease: moving forwards
por: Lane, Laura C, et al.
Publicado: (2023)

“Lymphocyte population in peripheral blood in children and adolescents with graves disease. Potential predictive tool for severity of the disease”
por: Tuli, Gerdi, et al.
Publicado: (2022)

Changes of Serum Angiotensin-Converting Enzyme Activity During Treatment of Patients with Graves’ Disease(*)
por: Lee, Dong Soo, et al.
Publicado: (1986)

Beta-blocker Rebound Phenomenon in an Adolescent with Graves’ Disease
por: Anık, Ahmet
Publicado: (2022)

Graves' Disease: Can It Be Cured?
por: Wiersinga, Wilmar M.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r2r8mgv0p10bkbsu0spds8aj2v